IM Cannabis (IMCC) Change in Account Payables (2020 - 2026)
IM Cannabis' (IMCC) quarterly Change in Account Payables came in at -$1.9 million in Q1 2026, down 152.61% year-on-year from $3.7 million in Q1 2025, and down 147.83% quarter-over-quarter from $4.0 million in Q4 2025.
IM Cannabis (IMCC) Change in Account Payables (2020 - 2026) Analysis & Trends
IM Cannabis' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 152.61% year-over-year to -$1.9 million in Q1 2026; TTM through Mar 2026 was -$4.5 million, a 150.5% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 78.25% from the prior year.
- Change in Account Payables retreated to -$1.9 million in Q1 2026 per IMCC's latest filing, from $4.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.9 million in Q2 2024 and bottomed at -$4.5 million in Q1 2023.
- The 5-year median for Change in Account Payables is $702018.7 (2023), against an average of $533640.1.
- Across the five-year window, Change in Account Payables plunged 337.33% in 2023 and soared 658.05% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $2.4 million in 2022, then tumbled by 144.17% to -$1.1 million in 2023, then sank by 85.34% to -$2.0 million in 2024, then jumped by 305.23% to $4.0 million in 2025, then slumped by 147.83% to -$1.9 million in 2026.
- Per Business Quant, the three latest IMCC Change in Account Payables figures stand at -$1.9 million (Q1 2026), $4.0 million (Q4 2025), and -$3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.93 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 492,021.06 |
| Mar 31, 2024 | 492,021.06 |
| Dec 31, 2023 | -1.06 Mn |
| Dec 31, 2023 | -1.06 Mn |